Ameritas Investment Partners’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.5K | Buy |
4,184
+700
| +20% | +$7.95K | ﹤0.01% | 2218 |
|
|
2025
Q1 | $23.2K | Hold |
3,484
| – | – | ﹤0.01% | 2487 |
|
|
2024
Q4 | $38.4K | Hold |
3,484
| – | – | ﹤0.01% | 2341 |
|
|
2024
Q3 | $42.8K | Hold |
3,484
| – | – | ﹤0.01% | 2280 |
|
|
2024
Q2 | $47.1K | Buy |
3,484
+1,206
| +53% | +$16.3K | ﹤0.01% | 2170 |
|
|
2024
Q1 | $30.8K | Hold |
2,278
| – | – | ﹤0.01% | 2393 |
|
|
2023
Q4 | $12K | Hold |
2,278
| – | – | ﹤0.01% | 2786 |
|
|
2023
Q3 | $8.98K | Hold |
2,278
| – | – | ﹤0.01% | 2866 |
|
|
2023
Q2 | $24.2K | Buy |
2,278
+781
| +52% | +$8.3K | ﹤0.01% | 2467 |
|
|
2023
Q1 | $12.5K | Hold |
1,497
| – | – | ﹤0.01% | 2642 |
|
|
2022
Q4 | $13.9K | Hold |
1,497
| – | – | ﹤0.01% | 2703 |
|
|
2022
Q3 | $19K | Hold |
1,497
| – | – | ﹤0.01% | 2556 |
|
|
2022
Q2 | $19K | Hold |
1,497
| – | – | ﹤0.01% | 2573 |
|
|
2022
Q1 | $32K | Hold |
1,497
| – | – | ﹤0.01% | 2331 |
|
|
2021
Q4 | $36K | Hold |
1,497
| – | – | ﹤0.01% | 2338 |
|
|
2021
Q3 | $38K | Hold |
1,497
| – | – | ﹤0.01% | 2344 |
|
|
2021
Q2 | $50K | Buy |
1,497
+418
| +39% | +$14K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $42K | Hold |
1,079
| – | – | ﹤0.01% | 2190 |
|
|
2020
Q4 | $67K | Hold |
1,079
| – | – | ﹤0.01% | 1813 |
|
|
2020
Q3 | $36K | Hold |
1,079
| – | – | ﹤0.01% | 2040 |
|
|
2020
Q2 | $26K | Sell |
1,079
-401
| -27% | -$9.66K | ﹤0.01% | 2219 |
|
|
2020
Q1 | $34K | Buy |
1,480
+719
| +94% | +$16.5K | ﹤0.01% | 1879 |
|
|
2019
Q4 | $22K | Hold |
761
| – | – | ﹤0.01% | 2372 |
|
|
2019
Q3 | $16K | Buy |
+761
| New | +$16K | ﹤0.01% | 2519 |
|